Browsing Tag
Elanco Animal Health
4 posts
Elanco (NYSE: ELAN) wins USDA nod for Befrena monoclonal antibody in canine dermatology
Elanco wins USDA approval for Befrena to treat canine dermatitis. Find out how this boosts its antibody strategy and reshapes competition in pet health.
January 1, 2026
Top U.S. gainers: Regencell, Disney, Rockwell, and Tempus AI spark broad market rally
Explore which U.S. stocks surged on May 7, 2025, and why investors rotated into biotech, AI, and healthcare amid Fed pauses and macro uncertainty.
May 8, 2025
Merck Animal Health announces $1.3bn acquisition of Elanco’s aqua business
Merck Animal Health, a division of Merck & Co., Inc., headquartered in Rahway, New Jersey, USA, has announced…
February 5, 2024
Bayer completes sale of animal health business to Elanco
Bayer has wrapped up its previously announced $7.6 billion sale of its animal health business division to US-based…
August 4, 2020